Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class

  1. Porta-Etessam, J.
  2. González-García, N.
  3. Guerrero, Á.L.
  4. García-Azorín, D.
Revue:
Neurologia

ISSN: 1578-1968,  0213-4853

Année de publication: 2021

Volumen: 36

Número: 8

Pages: 638-640

Type: Lettre

DOI: 10.1016/J.NRL.2020.10.009 GOOGLE SCHOLAR lock_openAccès ouvert editor